It has been developed using the Illumina technology. Almac has extensive expertise in developing multiplex diagnostics and have many multiplex RNA and DNA assays running in early phase trial ...

Developed utilising experience in peptide engineering and chemical synthesis and design, Almac's FLEXYTE™ assays harness the power and potential of FLT to provide an efficient and economical ...

Almac launches FLEXYTE® protease assay platform - the next step in utilization of fluorescent lifetime technology - at the 2010 Society for Biomolecular Sciences (SBS) meeting in Phoenix (11-15 April) ...

Almac focus on providing a range of services including exploratory biomarker discovery studies, verification studies for existing markers, assay development and biomarker validation. For more ...

Almac focus on providing a range of services including exploratory biomarker discovery studies, verification studies for existing markers, assay development and biomarker validation. The provides ...

The value of the collaboration was not disclosed. Almac said the alliance will enable it to develop NGS assays using Illumina’s MiSeqDx® instrument, the first FDA-cleared IVD NGS system ...

Under the terms of the agreement, Almac will develop and validate specific CDx assays for patient selection in various AstraZeneca clinical trials across a range of therapeutic areas including ...